Filter News
Area of Research
- (-) Supercomputing (48)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (35)
- Clean Energy (152)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (4)
- Electricity and Smart Grid (3)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (9)
- Isotope Development and Production (1)
- Isotopes (28)
- Materials (81)
- Materials for Computing (13)
- National Security (33)
- Neutron Science (29)
- Nuclear Science and Technology (9)
- Quantum information Science (4)
- Sensors and Controls (2)
- Transportation Systems (2)
News Topics
- (-) Biomedical (17)
- (-) Cybersecurity (8)
- (-) Energy Storage (8)
- (-) Grid (5)
- (-) Isotopes (1)
- (-) Microscopy (7)
- (-) Security (5)
- (-) Space Exploration (3)
- (-) Transportation (6)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (1)
- Artificial Intelligence (36)
- Big Data (19)
- Bioenergy (9)
- Biology (11)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (5)
- Climate Change (17)
- Computer Science (95)
- Coronavirus (14)
- Critical Materials (3)
- Decarbonization (5)
- Environment (21)
- Exascale Computing (22)
- Frontier (28)
- Fusion (1)
- High-Performance Computing (38)
- Machine Learning (14)
- Materials (15)
- Materials Science (16)
- Mathematics (1)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (8)
- Net Zero (1)
- Neutron Science (13)
- Nuclear Energy (4)
- Partnerships (1)
- Physics (7)
- Polymers (2)
- Quantum Computing (19)
- Quantum Science (24)
- Simulation (14)
- Software (1)
- Summit (42)
- Sustainable Energy (10)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
Researchers at ORNL used quantum optics to advance state-of-the-art microscopy and illuminate a path to detecting material properties with greater sensitivity than is possible with traditional tools.
ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.